Recent Research Grants

  • Rhythm Evaluation for AntiCoagulaTion for Atrial Fibrillation (REACT AF). Anne Curtis (Co-Investigator). NIH. $66,278. 8/1/2023-7/1/2029.
  • Posttranslational modifications of glucocorticoid receptor associated with drug resistance in prostate cancer. Remi Adelaiye-Ogala (Principal Investigator). NCI/NIH. 4/1/2024-5/1/2029.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2028.
  • NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.
  • Determining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannii. Thomas Russo (Principal Investigator). Veterans Administration. $1,359,244. 10/1/2019-9/1/2027.
  • Enhancing the translational potential of therapeutic exosomes for ischemic heart disease. Jennifer Lang (Principal Investigator). VA. $709,818. 10/1/2023-9/1/2027.
  • Training the Next Generation of Physician Scientists T35 Training Grant. Timothy Murphy (Principal Investigator). NIAID. $293,309. 9/1/2022-8/1/2027.
  • Mab Passive Vaccination against Acinetobacter baumannii. Thomas Russo (Co-Investigator). NIAID/NIH. $485,053. 9/1/2022-8/1/2027.
  • Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer. Brahm Segal (Principal Investigator). NCI. $3,310,823. 8/1/2022-8/1/2027.
  • Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa. Thomas Russo (Co-Investigator). NIAID/NIH. 5/1/2022-4/1/2027.
  • The benefits of nicotinamide riboside upon cognition and sleep in older adults. M. Jeffery Mador (Co-Investigator). NIH. 3/1/2023-3/1/2027.
  • Impacts of Nicotinamide Riboside on functional capacity and muscle physiology in older veterans. Nikhil Satchidanand (Co-Investigator). Veterans Affairs. 1/1/2022-12/1/2026.
  • A brief, transdiagnostic cognitive behavioral treatment for urologic chronic pelvic pain syndrome (UCPPS): Process, predictions, outcomes. Tova Ablove (Co-Investigator), Teresa Danforth (Co-Investigator), Gregory Gudleski (Co-Investigator), Jeffrey Lackner (Principal Investigator), Christopher Radziwon (Co-Investigator). NIH NIDDK. $3,288,753. 9/1/2021-7/1/2026.
  • Primary Care Training and Enhancement -Community Prevention and Maternal Health for Preventive Medicine residency and Combined Internal Medicine/Preventive Medicine Residency, University at Buffalo Title: The UB Preventive Medicine Program in Maternal Health Improvement Total Award- $2,840,574. Smita Bakhai (Principal Investigator). HRSA. $2,840,574. 7/1/2021-6/1/2026.
  • Immunomodulation of Galectin-3 to Prevent Radiation-Induced Myocardial Fibrogenesis. Umesh Sharma (Principal Investigator). NHLBI. $1,726,588. 3/1/2021-3/1/2026.
  • Physician Advisor - NIH - R01-Grant Sleep Effects on Post-Stroke Rehabilitation. Eric Ten Brock (Principal Investigator). $3,051,980. 1/1/2021-1/1/2026.
  • A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cance. Stanley Schwartz (Principal Investigator). Department of Veterans Affairs. 1/1/2022-12/1/2025.
  • Inhibition of Radiation-Induced Coronary Microvascular Disease. Supriya Mahajan (Co-Investigator). NIH. $1,750,000. 9/1/2020-8/1/2025.
  • Troup Fund/Kaleida Health Foundation Liver Center of Western New York. Andrew Talal (Principal Investigator). Troup Fund/Kaleida Health Foundation Liver Center of Western New York. $3,067,590. 7/1/2018-6/1/2025.
  • Dec 2023- Jun 2025 Implementation of Multi-Faced Strategies to Advance Health Equity in Colorectal Cancer Screening in Marginalized Communities at Hertel Elmwood Internal Medicine Clinic , Buffalo Sponsor: Exact Sciences Funding: $75,000 to Kaleida Health Foundation Role: PI and Lead Physician. Smita Bakhai (Principal Investigator). Exact sciences. 12/1/2023-6/1/2025.